Wellington Management Group LLP Buys 2,584 Shares of Cigna Group $CI

Posted by George Bondi on Sep 7th, 2026

Wellington Management Group LLP lifted its stake in shares of Cigna Group (NYSE:CI – Free Report) by 4.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,855 shares of the health services provider’s stock after purchasing an additional 2,584 shares during the quarter. Wellington Management Group LLP’s holdings in Cigna Group were worth $17,328,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in CI. Kingsview Wealth Management LLC bought a new stake in Cigna Group in the 2nd quarter valued at about $10,291,000. Beacon Pointe Advisors LLC bought a new position in Cigna Group in the second quarter worth approximately $11,015,000. Livforsakringsbolaget Skandia Omsesidigt bought a new position in Cigna Group in the second quarter worth approximately $3,037,000. Twin Lakes Capital Management LLC acquired a new stake in Cigna Group in the second quarter valued at approximately $174,000. Finally, Rakuten Investment Management Inc. acquired a new stake in Cigna Group in the second quarter valued at approximately $12,046,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on CI shares. Barclays upped their target price on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Guggenheim boosted their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Mizuho upped their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research note on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price objective for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $339.45.

Read Our Latest Stock Report on CI

Cigna Group Stock Performance

NYSE CI opened at $282.24 on Monday. The company has a fifty day moving average price of $283.51 and a 200-day moving average price of $281.00. The firm has a market cap of $74.58 billion, a price-to-earnings ratio of 11.68, a PEG ratio of 0.97 and a beta of 0.31. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47.

Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period last year, the firm earned $7.20 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Buying and Selling

In related news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 23,012 shares of company stock worth $6,386,550 in the last 90 days. Company insiders own 0.60% of the company’s stock.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.